By Sarah Owermohle Bourla has repeatedly said that Pfizer could apply for emergency authorization from the FDA sometime in October, the most ambitious target laid out by any of the vaccine developers whose shots are now in late-stage U.S trials. His memo to staff Thursday sticks to that goal while also asserting Pfizer’s independence in […]
Pfizer CEO: ‘Disappointed’ in presidential debate, vows no political pressure on Covid shot
from Newslanes https://ift.tt/3jnfMlZ
0 comments:
Post a Comment